Does ACALABRUTINIB Cause Aplastic anaemia? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Aplastic anaemia have been filed in association with ACALABRUTINIB (CALQUENCE). This represents 0.2% of all adverse event reports for ACALABRUTINIB.
19
Reports of Aplastic anaemia with ACALABRUTINIB
0.2%
of all ACALABRUTINIB reports
3
Deaths
4
Hospitalizations
How Dangerous Is Aplastic anaemia From ACALABRUTINIB?
Of the 19 reports, 3 (15.8%) resulted in death, 4 (21.1%) required hospitalization, and 4 (21.1%) were considered life-threatening.
Is Aplastic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ACALABRUTINIB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does ACALABRUTINIB Cause?
Death (1,857)
Fatigue (536)
Headache (534)
Product dose omission issue (349)
Diarrhoea (320)
Fall (289)
Malignant neoplasm progression (285)
Contusion (270)
Dyspnoea (259)
Pneumonia (244)
What Other Drugs Cause Aplastic anaemia?
ECULIZUMAB (345)
CYCLOPHOSPHAMIDE (332)
CYCLOSPORINE (331)
METHOTREXATE (281)
BUSULFAN (220)
FLUDARABINE (220)
ETOPOSIDE (186)
VINCRISTINE (173)
CYTARABINE (163)
ELTROMBOPAG OLAMINE (149)
Which ACALABRUTINIB Alternatives Have Lower Aplastic anaemia Risk?
ACALABRUTINIB vs ACAMPROSATE
ACALABRUTINIB vs ACARBOSE
ACALABRUTINIB vs ACCUTANE
ACALABRUTINIB vs ACEBUTOLOL
ACALABRUTINIB vs ACECLOFENAC